Page last updated: 2024-11-05

trioxsalen and Graft-Versus-Host Disease

trioxsalen has been researched along with Graft-Versus-Host Disease in 1 studies

Trioxsalen: Pigmenting photosensitizing agent obtained from several plants, mainly Psoralea corylifolia. It is administered either topically or orally in conjunction with ultraviolet light in the treatment of vitiligo.
lactone : Any cyclic carboxylic ester containing a 1-oxacycloalkan-2-one structure, or an analogue having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.
antipsoriatic : A drug used to treat psoriasis.
trioxsalen : 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phototherapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grass, JA1
Hei, DJ1
Metchette, K1
Cimino, GD1
Wiesehahn, GP1
Corash, L1
Lin, L1

Other Studies

1 other study available for trioxsalen and Graft-Versus-Host Disease

ArticleYear
Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.
    Blood, 1998, Mar-15, Volume: 91, Issue:6

    Topics: Adult; DNA Adducts; DNA Damage; Gamma Rays; Graft vs Host Disease; Humans; Interleukin-8; Leukocyte

1998